Vrije Universiteit Brussel’s Camel-IDS collected funding from investors including Novo for a radiation-based oncology platform that will initially target Her2-positive brain metastatic breast cancer.

Vrije Universiteit Brussel’s Camel-IDS collected funding from investors including Novo for a radiation-based oncology platform that will initially target Her2-positive brain metastatic breast cancer.

OSI is among the investors in drone developer Animal Dynamics’ latest round, which will help it develop products based on aerodynamics from the animal kingdom.

Merck Group's M Ventures unit led the RNA therapy startup's series A round, which featured Amgen, Illumina, AbbVie and Mitsubishi Tanabe Pharma.

Intel Capital led a round for the network cybersecurity platform developer that included ADT, with the cash to go to international growth and research and development.

The soil analytics provider took its total funding to $19m in a round featuring agricultural investment, data and media platform AgFunder.

Nasdaq Ventures, Macquarie Capital and UST Global have helped cybersecurity technology developer XM Cyber close a series A round, bringing its total funding to $32m.

Previously backed by Stanford University, Origin has now raised a total of $12.3m to support its modular and interoperable approach to 3D printing.

37 Interactive Entertainment and existing backer TAL Education both invested in a $14.4m round for the children's literature platform.

Penn spinout Cabaletta Bio’s first funding round includes university investment and it will use the cash to develop T-cell drugs for autoimmune diseases including pemphigus vulgaris.